Analyzing heart rate and blood pressure data with AI models compared to traditional scoring systems regularly used in ICUs enables earlier detection of deterioration, more accurate mortality prediction, and targeted interventions to save patients. AI models, by leveraging real-time, high-frequency physiological data and advanced machine learning techniques, such as gradient boosting and neural networks, clearly outperform traditional scoring systems and can identify subtle patterns and risk factors that may be missed by standard approaches. This way, AI-based systems can alert for high-risk patients, prompting earlier clinical interventions to save lives. Additionally, by identifying patient-specific risk profiles, AI models support tailored interventions, such as optimizing ventilator settings or medication adjustments, leading to better outcomes and more efficient use of ICU resources. All of these improvements have been shown to reduce all-cause mortality in ICUs. I see significant promise in personalized ICU care using AI models, but there are several key limitations that need to be addressed to make the use of these technologies more mainstream. The first limitation is generalizability. Many of these AI models are developed and tested on single-center or limited datasets, leading to poor generalizability across different hospitals. Another limitation is the lack of transparency. Complex AI models function as "black boxes," making it hard for clinicians to understand or trust their predictions, and this can hinder clinical adoption and integration. AI models may inherit biases from training data, leading to unequal performance across demographic groups or clinical subtypes. This can result in disparities in care or misclassification of risk. With that being said, I believe that the use of these AI models is the future, and Ongoing research and collaboration between data scientists and clinicians are key to overcoming these barriers to facilitate the use of these new technologies in healthcare. Thank you Dr. Seyed Hassan Fakher MD Preventive Health & Sports Medicine https://www.linkedin.com/in/hassan-fakher-md-322615244/ Dr.fakher@invigormedical.com Invigor Medical
Using AI to personalize heart and blood pressure monitoring could really change the game in critical care. It means doctors can intervene in earlier treatments more accurately. This way, medical teams can stay ahead of patient issues, possibly stopping crises before they blow up and cause bigger problems. A big challenge is ensuring that AI forecasts are accurate and consistent across various types of patients and complicated medical scenarios. We definitely should continue validating and testing against actual world data, just as with the meticulous protocols in air medical transport, in order to gain confidence and ensure that the resulting Ai insights translate into tangible benefits in terms of patient safety and survivability.
Personalising blood pressure and heart rate targets through AI may help clinicians move beyond the one-size-fits-all thresholds commonly applied in the ICU. All patients react to disease and therapy in their own way, and AI systems that combine real-time physiologic measurements can identify subtle warning signs sooner. Practically, this could involve setting blood pressure targets in a way that avoids kidney damage in one patient or avoiding excessively vigorous treatment that would cause a decline in perfusion in another. The outcome is safer and more accurate care. That said, there are limits. The quality of AI models is only as good as the data on which they are trained. When datasets do not represent specific groups of patients, the recommendations made by them may not be generalised well. Another challenge is integrating into busy ICU workflows, in which case the tools must increase decision-making speed, rather than slow it down. Such limits may be enhanced by testing models on a variety of populations, integrating AI into current monitoring, and maintaining clinicians in the loop to reconcile algorithmic knowledge with bedside expertise.
This type of AI tech offers a huge potential for patients receiving home healthcare, who typically need close monitoring yet want to recuperate in their homes. The major reason home care fails is the inability to identify early warning signs of decline. With AI monitoring, we could potentially identify problems even six hours prior to them becoming a significant issue for the patient which gives families and nurses sufficient time to take action. The biggest advantage is personalized care. Instead of using average numbers for everyone, the AI learns what normal looks like for each specific patient. For example, the normal resting heart rate of a 75-year old person with heart disease may be healthy at 90, while normal guidelines say an acceptable resting heart rate is 70. Incorrectly identifying acute signs like this may unnecessarily cause panic to families or completely miss a true patient emergency. The main problem with this is data quality. Hospital AI systems work with complete medical records and constant monitoring. Home patients often have incomplete records spread across different doctors and hospitals. We need better ways to collect and share patient information safely. Real-world testing is missing too. Hospital data doesn't account for home variables like forgetting medications, walking the dog or dealing with stress. We need 12-month studies with actual home patients to prove this technology works outside controlled hospital environments. Without proper validation, we risk creating expensive systems that sound good but fail when patients and their families need them most.
How can the findings help improve care? This technology is a step forward in personalized medicine. Rather than using standard alarms, AI creates a patient's unique cardiac and blood pressure "fingerprint" and alerts to changes, which are significant for that individual. This can reveal the gradual worsening of the condition earlier, reduce the number of false alarms, and provide healthcare professionals with the ability to accurately adjust the timing (of drug, dosage, increase of support) as well as the quantity. When these algorithms are combined with the results from the monitor and the EHR, and there are clear and understandable prompts, they move the decisions from the use of a single threshold to actual patient-specific signals, which is a convenient way to avoid deaths in the ICU caused by shock." Are there any potential limits, and how can those be improved? Limitations are practical: models trained on narrow datasets may not generalize; bedside signals are noisy or missing; opaque outputs erode clinician trust; and bad calibration can worsen alarm fatigue. Fixes are straightforward: validate across diverse hospitals, run prospective trials that measure real outcomes, add uncertainty estimates and interpretable explanations, build clinician-in-the-loop workflows, and continuously recalibrate models post-deployment. Couple that with signal-quality checks, equity audits to catch bias, and strong data governance — then the tech becomes a reliable tool, not just a flashy experiment.